Drugs / RM-004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06107400 | Oct 2023 → Oct 2025 overdue | hemoglobin H disease | The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RM-004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06107400 ↗ |
| Modality | Cell therapy | “gene-edited CD34+autologous hematopoietic stem cells” NCT06107400 ↗ |
| Route | Intravenous | “single intravenous infusion” NCT06107400 ↗ |